﻿               SEQUENCE LISTING

<110> UNIVERSITÄT LEIPZIG
      

<120> PEPTIDIC BB2 RECEPTOR AGONIST – SACCHARIDE FUNCTIONALISED CARBABORANE CONJUGATES

<130> BHC 17 3 030EP01

<160> 3

<170> BiSSAP 1.3.6

<210> 1
<211> 8
<212> PRT
<213> synthetic peptide


<220> 
<223> Ala in position 6 means ß-Ala; Phe is D-form; all others, including Ala in position 4 and 8, are L-form, Leu means L-Norleucine, 
	Phe is optionally conjugated to a carbaborane,
<400> 1
Phe Gln Trp Ala Val Ala His Ala Leu
1               5                    

<210> 2
<211> 11
<212> PRT
<213> synthetic peptide


<220> 
<223> Ala in position 9 means ß-Ala; Phe is D-form; all others, including Ala in position 7 and 11, are L-form, Leu means L-Norleucine, 
	Phe is conjugated to a carbaborane,
<400> 2
Ser Ser Ser Phe Gln Trp Ala Val Ala His Ala Leu 
1               5                   10      

<210> 3
<211> 13
<212> PRT
<213> synthetic peptide


<220> 
<223> Ala in position 11 means ß-Ala; Phe is D-form; all others, including Ala in position 9 and 13 but except Gly, are L-form, 
	Leu means L-Norleucine, Phe is conjugated to a carbaborane,
<400> 3
Ser Gly Ser Gly Ser Phe Gln Trp Ala Val Ala His Ala Leu 
1               5                   10              


<210> 4
<211> 8
<212> PRT
<213> synthetic peptide

<220> 
<223> Ala in position 6 means ß-Ala; Phe is D-form in position 1 and L-form in position 8; all others, including Ala in position 4, 
	are L-form, Leu means L-Norleucine, no carbaborane conjugation,
<400> 4
Phe Gln Trp Ala Val Ala His Phe Leu
1               5                  
